Hron G	FIS_2109
Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation.
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.
The impact of noninvasive, capillary, and venous hemoglobin screening on donor deferrals and the hemoglobin content of red blood cells concentrates: a prospective study.
Neue orale Antikoagulanzien in der Nephrologie
Thrombin generation, ProC(Â®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation
PDK1 Determines Collagen-Dependent Platelet Ca2+ Signaling and Is Critical to Development of Ischemic Stroke In Vivo.